A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
Clinical trial NCT02117830 · COMPLETED
Trial details
- NCT number
- NCT02117830
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-05-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.